Richard Wachman The Observer,Sunday 6 December 2009
Drugs giant GSK is scouring the globe for acquisitions and could splash out more than $3bn to expand in consumer healthcare, over-the-counter medicines, generics and vaccines.
Analysts say the company is looking at acquiring Dr Reddy's, the Indian generics firm that has large selling operations in Africa, the Middle East and Latin America. Other targets include Genmab, the Danish biotechnology company, Theravance of the US and Aspen, the South African generics firm.
GSK is keen to expand further in emerging markets, especially India and China, where pharmaceutical groups are keen to strike licensing and marketing agreements with Western rivals.
No hay comentarios:
Publicar un comentario